Browse Diabetic nephropathies topic

Subtopics (11)

• Analysis
• Care and treatment
• Complications and side effects
• Development and progression
• Diagnosis
• Diet therapy
• Drug therapy
• Genetic aspects
• Prevention
• Research
• Risk factors

Articles

Title	Author	Type	Date	Words
Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.		Clinical report	Jul 1, 2009	262
Renoprotective effects of the age-inhibitor pyridoxamine in experimental chronic allograft nephropathy in rats.		Brief article	Jul 1, 2009	295
Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: mechanism of action of Pyridoxamine.		Report	Jul 1, 2009	261
Vitamin B1 helps reverse early kidney disease in diabetics.	Dye, Dayna	Report	Mar 1, 2009	181
Naturopathic approaches to diabetic kidney disease.	Tan, Alex; Leone, Jacob	Clinical report	Feb 1, 2009	4356
Reata Pharmaceuticals Contracts ApoCell to Detect Innovative Biomarkers in a Phase II Clinical Study of RTA 402 for Diabetic Renal Disease.		Clinical report	Jun 10, 2008	380
Case Western Reserve University and TGen Select Affymetrix SNP Array 6.0 for Diabetes Study.			Jun 9, 2008	892
Target Product Profiles 2008: Physician Insights on Key Attributes - Diabetic Nephropathy.			May 13, 2008	691
Gain Insight into the Pipeline Status of Diabetic Nephropathy Drugs by Company and by Stage and Also Get a Summary of the Latest News and Developments in This Area.			Sep 14, 2007	375
Data Supports Potential Mechanism for Gentium's Defibrotide in Cancer, Diabetic Nephropathy and Veno-Occlusive Disease.			Jul 16, 2007	875
William Blair & Company Initiates Coverage of Exelixis Inc. With Outperform Rating.		Company overview	Jun 29, 2007	372
Gentium's Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology.			Apr 23, 2007	561
Ginkgo biloba extract protects rat kidney from diabetic and hypoxic damage.	Welt, K.; Weiss, J.; Martin, R.; Hermsdorf, T.; Drews, S.; Fitzl, G.	Drug overview	Feb 1, 2007	2962
Southern Medical Journal CME Topic: improving antihypertensive therapy in patients with diabetic nephropathy.			Feb 1, 2006	576
Improving antihypertensive therapy in patients with diabetic nephropathy.	Mende, Christian W.		Feb 1, 2006	5815
Hypertension and Diabetic Kidney Disease -- Commercial Performance of Both ACE Inhibitors and ARBS is Dependent on Renoprotective Benefits beyond Blood Pressure Control.			Dec 23, 2005	339
High body mass index linked to chronic kidney disease.	Tucker, Miriam E.		Aug 1, 2005	444
Secondary analyses in obesity, diabetes, digestive and kidney diseases.			Jul 1, 2005	1220
Angiotensin-receptor blockade vs converting-enzyme inhibition in type 2 diabetes and nephropathy.	Kuritzky, Louis	Brief Article	Jan 1, 2005	202
ARB and ACE-I in diabetic nephropathy.	Kuritzky, Louis	Brief Article	Nov 1, 2003	175
Amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients.	Kuritzky, Louis	Brief Article	Mar 1, 2003	185
Hypertension a critical issue. (Health).	Ungar, Linda		Mar 1, 2003	877
Kidney disease of diabetes.		Pamphlet	Apr 1, 2001	2778
Prevent diabetes problems: Keep your kidneys healthy.		Pamphlet	May 17, 2000	1908
Study links nephropathy with familial risk of stroke.			Apr 1, 1999	103
Kidney disease of diabetes.		Pamphlet	Jul 1, 1995	2527